List of MeSH codes (C20)
For other categories, see List of MeSH codes.
The following is a list of the "C" codes for MeSH. It is a product of the United States National Library of Medicine.
Source for content is here. (File "2006 MeSH Trees".)
MeSH C20 --- immune system diseases
MeSH C20.111 --- autoimmune diseases
MeSH C20.111.199 --- arthritis, rheumatoid
- MeSH C20.111.199.114 --- arthritis, juvenile rheumatoid
- MeSH C20.111.199.389 --- felty's syndrome
- MeSH C20.111.199.774 --- sjogren's syndrome
- MeSH C20.111.199.856 --- spondylitis, ankylosing
- MeSH C20.111.199.870 --- still's disease, adult-onset
MeSH C20.111.258 --- autoimmune diseases of the nervous system
- MeSH C20.111.258.250 --- demyelinating autoimmune diseases, cns
- MeSH C20.111.258.250.175 --- diffuse cerebral sclerosis of schilder
- MeSH C20.111.258.250.350 --- encephalomyelitis, acute disseminated
- MeSH C20.111.258.250.425 --- leukoencephalitis, acute hemorrhagic
- MeSH C20.111.258.250.500 --- multiple sclerosis
- MeSH C20.111.258.250.500.200 --- multiple sclerosis, chronic progressive
- MeSH C20.111.258.250.500.600 --- multiple sclerosis, relapsing-remitting
- MeSH C20.111.258.250.500.650 --- neuromyelitis optica
- MeSH C20.111.258.250.550 --- myelitis, transverse
- MeSH C20.111.258.250.550.500 --- neuromyelitis optica
- MeSH C20.111.258.250.600 --- neuromyelitis optica
- MeSH C20.111.258.350 --- lambert-eaton myasthenic syndrome
- MeSH C20.111.258.450 --- leukoencephalitis, acute hemorrhagic
- MeSH C20.111.258.500 --- myasthenia gravis
- MeSH C20.111.258.500.300 --- myasthenia gravis, autoimmune, experimental
- MeSH C20.111.258.500.650 --- myasthenia gravis, neonatal
- MeSH C20.111.258.625 --- nervous system autoimmune disease, experimental
- MeSH C20.111.258.625.300 --- encephalomyelitis, autoimmune, experimental
- MeSH C20.111.258.625.350 --- myasthenia gravis, autoimmune, experimental
- MeSH C20.111.258.625.700 --- neuritis, autoimmune, experimental
- MeSH C20.111.258.750 --- polyradiculoneuropathy
- MeSH C20.111.258.750.400 --- guillain-barre syndrome
- MeSH C20.111.258.750.400.500 --- miller fisher syndrome
- MeSH C20.111.258.750.600 --- hereditary sensory and autonomic neuropathies
- MeSH C20.111.258.750.600.250 --- dysautonomia, familial
- MeSH C20.111.258.750.800 --- polyradiculoneuropathy, chronic inflammatory demyelinating
- MeSH C20.111.258.850 --- stiff-person syndrome
- MeSH C20.111.258.925 --- uveomeningoencephalitic syndrome
- MeSH C20.111.258.962 --- vasculitis, central nervous system
- MeSH C20.111.258.962.400 --- lupus vasculitis, central nervous system
- MeSH C20.111.258.962.800 --- temporal arteritis
MeSH C20.111.555 --- graves disease
MeSH C20.111.590 --- lupus erythematosus, systemic
- MeSH C20.111.590.560 --- lupus nephritis
- MeSH C20.111.590.750 --- lupus vasculitis, central nervous system
MeSH C20.111.736 --- pemphigus
MeSH C20.188 --- blood group incompatibility
MeSH C20.188.413 --- erythroblastosis, fetal
MeSH C20.543 --- hypersensitivity
MeSH C20.543.206 --- drug hypersensitivity
- MeSH C20.543.206.380 --- drug eruptions
- MeSH C20.543.206.380.350 --- epidermal necrolysis, toxic
- MeSH C20.543.206.380.375 --- erythema nodosum
- MeSH C20.543.206.380.800 --- serum sickness
MeSH C20.543.312 --- environmental illness
- MeSH C20.543.312.500 --- multiple chemical sensitivity
- MeSH C20.543.312.750 --- sick building syndrome
MeSH C20.543.418 --- hypersensitivity, delayed
- MeSH C20.543.418.150 --- dermatitis, allergic contact
- MeSH C20.543.418.150.600 --- dermatitis, photoallergic
- MeSH C20.543.418.150.700 --- dermatitis, toxicodendron
MeSH C20.543.480 --- hypersensitivity, immediate
- MeSH C20.543.480.099 --- anaphylaxis
- MeSH C20.543.480.200 --- conjunctivitis, allergic
- MeSH C20.543.480.343 --- dermatitis, atopic
- MeSH C20.543.480.370 --- food hypersensitivity
- MeSH C20.543.480.370.150 --- egg hypersensitivity
- MeSH C20.543.480.370.500 --- milk hypersensitivity
- MeSH C20.543.480.370.550 --- nut hypersensitivity
- MeSH C20.543.480.370.675 --- peanut hypersensitivity
- MeSH C20.543.480.370.850 --- wheat hypersensitivity
- MeSH C20.543.480.680 --- respiratory hypersensitivity
- MeSH C20.543.480.680.075 --- alveolitis, extrinsic allergic
- MeSH C20.543.480.680.075.125 --- bird fancier's lung
- MeSH C20.543.480.680.075.365 --- farmer's lung
- MeSH C20.543.480.680.085 --- aspergillosis, allergic bronchopulmonary
- MeSH C20.543.480.680.095 --- asthma
- MeSH C20.543.480.680.095.110 --- asthma, exercise-induced
- MeSH C20.543.480.680.095.880 --- status asthmaticus
- MeSH C20.543.480.680.791 --- rhinitis, allergic, perennial
- MeSH C20.543.480.680.795 --- rhinitis, allergic, seasonal
- MeSH C20.543.480.904 --- urticaria
- MeSH C20.543.480.904.066 --- angioneurotic edema
MeSH C20.543.520 --- immune complex diseases
- MeSH C20.543.520.100 --- arthus reaction
- MeSH C20.543.520.770 --- serum sickness
- MeSH C20.543.520.910 --- vasculitis, hypersensitivity
- MeSH C20.543.520.910.580 --- purpura, schoenlein-henoch
- MeSH C20.543.520.910.952 --- vasculitis, allergic cutaneous
MeSH C20.673 --- immunologic deficiency syndromes
MeSH C20.673.430 --- dysgammaglobulinemia
MeSH C20.673.480 --- hiv infections
- MeSH C20.673.480.040 --- acquired immunodeficiency syndrome
- MeSH C20.673.480.048 --- aids arteritis, central nervous system
- MeSH C20.673.480.050 --- aids-associated nephropathy
- MeSH C20.673.480.070 --- aids dementia complex
- MeSH C20.673.480.080 --- aids-related complex
- MeSH C20.673.480.100 --- aids-related opportunistic infections
- MeSH C20.673.480.400 --- hiv-associated lipodystrophy syndrome
- MeSH C20.673.480.480 --- hiv enteropathy
- MeSH C20.673.480.500 --- hiv seropositivity
- MeSH C20.673.480.520 --- hiv wasting syndrome
MeSH C20.673.483 --- deltaretrovirus infections
- MeSH C20.673.483.260 --- enzootic bovine leukosis
- MeSH C20.673.483.470 --- htlv-i infections
- MeSH C20.673.483.470.300 --- leukemia-lymphoma, t-cell, acute, htlv-i-associated
- MeSH C20.673.483.480 --- htlv-ii infections
- MeSH C20.673.483.480.350 --- leukemia, t-cell, htlv-ii-associated
MeSH C20.673.627 --- lymphopenia
- MeSH C20.673.627.800 --- t-lymphocytopenia, idiopathic cd4-positive
MeSH C20.673.774 --- phagocyte bactericidal dysfunction
- MeSH C20.673.774.257 --- chediak-higashi syndrome
- MeSH C20.673.774.257.270 --- aleutian mink disease
- MeSH C20.673.774.535 --- granulomatous disease, chronic
- MeSH C20.673.774.600 --- job's syndrome
MeSH C20.683 --- immunoproliferative disorders
MeSH C20.683.460 --- hypergammaglobulinemia
MeSH C20.683.515 --- lymphoproliferative disorders
- MeSH C20.683.515.250 --- giant lymph node hyperplasia
- MeSH C20.683.515.501 --- immunoblastic lymphadenopathy
- MeSH C20.683.515.512 --- immunoproliferative small intestinal disease
- MeSH C20.683.515.515 --- infectious mononucleosis
- MeSH C20.683.515.517 --- leukemia, hairy cell
- MeSH C20.683.515.528 --- leukemia, lymphocytic
- MeSH C20.683.515.639 --- leukemia, myeloid
- MeSH C20.683.515.639.550 --- leukemia, nonlymphocytic, acute
- MeSH C20.683.515.639.550.512 --- leukemia, myelocytic, acute
- MeSH C20.683.515.695 --- leukemia, plasmacytic
- MeSH C20.683.515.710 --- lymphangiomyoma
- MeSH C20.683.515.710.465 --- lymphangioleiomyomatosis
- MeSH C20.683.515.761 --- lymphoma
- MeSH C20.683.515.761.355 --- hodgkin disease
- MeSH C20.683.515.761.480 --- lymphoma, non-hodgkin
- MeSH C20.683.515.761.480.150 --- lymphoma, b-cell
- MeSH C20.683.515.761.480.150.165 --- burkitt lymphoma
- MeSH C20.683.515.761.480.150.450 --- lymphoma, aids-related
- MeSH C20.683.515.761.480.150.570 --- lymphoma, mucosa-associated lymphoid tissue
- MeSH C20.683.515.761.480.150.700 --- lymphoma, small-cell
- MeSH C20.683.515.761.480.300 --- lymphoma, diffuse
- MeSH C20.683.515.761.480.300.300 --- lymphoma, large-cell, diffuse
- MeSH C20.683.515.761.480.300.450 --- lymphoma, large-cell, immunoblastic
- MeSH C20.683.515.761.480.300.475 --- lymphoma, lymphoblastic
- MeSH C20.683.515.761.480.300.500 --- lymphoma, mixed-cell, diffuse
- MeSH C20.683.515.761.480.300.725 --- lymphoma, small cleaved-cell, diffuse
- MeSH C20.683.515.761.480.300.725.500 --- lymphoma, mantle-cell
- MeSH C20.683.515.761.480.300.750 --- lymphoma, small lymphocytic
- MeSH C20.683.515.761.480.300.775 --- lymphoma, small noncleaved-cell
- MeSH C20.683.515.761.480.350 --- lymphoma, follicular
- MeSH C20.683.515.761.480.350.350 --- lymphoma, large-cell, follicular
- MeSH C20.683.515.761.480.350.525 --- lymphoma, mixed-cell, follicular
- MeSH C20.683.515.761.480.350.750 --- lymphoma, small cleaved-cell, follicular
- MeSH C20.683.515.761.480.425 --- lymphoma, high-grade
- MeSH C20.683.515.761.480.425.450 --- lymphoma, large-cell, immunoblastic
- MeSH C20.683.515.761.480.425.475 --- lymphoma, lymphoblastic
- MeSH C20.683.515.761.480.425.775 --- lymphoma, small noncleaved-cell
- MeSH C20.683.515.761.480.425.775.165 --- burkitt lymphoma
- MeSH C20.683.515.761.480.450 --- lymphoma, intermediate-grade
- MeSH C20.683.515.761.480.450.300 --- lymphoma, large-cell, diffuse
- MeSH C20.683.515.761.480.450.350 --- lymphoma, large-cell, follicular
- MeSH C20.683.515.761.480.450.500 --- lymphoma, mixed-cell, diffuse
- MeSH C20.683.515.761.480.450.725 --- lymphoma, small cleaved-cell, diffuse
- MeSH C20.683.515.761.480.450.725.500 --- lymphoma, mantle-cell
- MeSH C20.683.515.761.480.475 --- lymphoma, large-cell
- MeSH C20.683.515.761.480.475.300 --- lymphoma, large-cell, diffuse
- MeSH C20.683.515.761.480.475.350 --- lymphoma, large-cell, follicular
- MeSH C20.683.515.761.480.475.450 --- lymphoma, large-cell, immunoblastic
- MeSH C20.683.515.761.480.475.465 --- lymphoma, large-cell, ki-1
- MeSH C20.683.515.761.480.475.475 --- lymphoma, lymphoblastic
- MeSH C20.683.515.761.480.500 --- lymphoma, low-grade
- MeSH C20.683.515.761.480.500.525 --- lymphoma, mixed-cell, follicular
- MeSH C20.683.515.761.480.500.570 --- lymphoma, mucosa-associated lymphoid tissue
- MeSH C20.683.515.761.480.500.750 --- lymphoma, small cleaved-cell, follicular
- MeSH C20.683.515.761.480.500.770 --- lymphoma, small lymphocytic
- MeSH C20.683.515.761.480.550 --- lymphoma, mixed-cell
- MeSH C20.683.515.761.480.550.500 --- lymphoma, mixed-cell, diffuse
- MeSH C20.683.515.761.480.550.525 --- lymphoma, mixed-cell, follicular
- MeSH C20.683.515.761.480.700 --- lymphoma, small-cell
- MeSH C20.683.515.761.480.700.725 --- lymphoma, small cleaved-cell, diffuse
- MeSH C20.683.515.761.480.700.725.500 --- lymphoma, mantle-cell
- MeSH C20.683.515.761.480.700.730 --- lymphoma, small cleaved-cell, follicular
- MeSH C20.683.515.761.480.700.750 --- lymphoma, small lymphocytic
- MeSH C20.683.515.761.480.700.775 --- lymphoma, small noncleaved-cell
- MeSH C20.683.515.761.480.750 --- lymphoma, t-cell
- MeSH C20.683.515.761.480.750.475 --- lymphoma, lymphoblastic
- MeSH C20.683.515.761.480.750.800 --- lymphoma, t-cell, cutaneous
- MeSH C20.683.515.761.480.750.800.465 --- lymphoma, large-cell, ki-1
- MeSH C20.683.515.761.480.750.800.550 --- mycosis fungoides
- MeSH C20.683.515.761.480.750.800.775 --- sezary syndrome
- MeSH C20.683.515.761.480.750.825 --- lymphoma, t-cell, peripheral
- MeSH C20.683.515.761.480.875 --- lymphoma, undifferentiated
- MeSH C20.683.515.761.480.875.300 --- lymphoma, large-cell, diffuse
- MeSH C20.683.515.761.480.875.775 --- lymphoma, small noncleaved-cell
- MeSH C20.683.515.761.480.875.775.165 --- burkitt lymphoma
- MeSH C20.683.515.761.720 --- plasmacytoma
- MeSH C20.683.515.761.720.550 --- multiple myeloma
- MeSH C20.683.515.761.802 --- reticuloendotheliosis
- MeSH C20.683.515.761.802.750 --- mast-cell sarcoma
- MeSH C20.683.515.840 --- marek disease
- MeSH C20.683.515.920 --- sezary syndrome
- MeSH C20.683.515.950 --- tumor lysis syndrome
MeSH C20.683.780 --- paraproteinemias
- MeSH C20.683.780.250 --- cryoglobulinemia
- MeSH C20.683.780.490 --- heavy chain disease
- MeSH C20.683.780.490.512 --- immunoproliferative small intestinal disease
- MeSH C20.683.780.640 --- monoclonal gammopathies, benign
- MeSH C20.683.780.640.700 --- schnitzler syndrome
- MeSH C20.683.780.650 --- multiple myeloma
- MeSH C20.683.780.750 --- poems syndrome
- MeSH C20.683.780.925 --- waldenstrom macroglobulinemia
This article is issued from Wikipedia - version of the 6/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.